CKPT logo

Checkpoint Therapeutics (CKPT) Revenue

Annual Revenue

$103.00 K
-$89.00 K-46.35%

31 December 2023

CKPT Revenue Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Revenue

N/A

30 September 2024

CKPT Quarterly Revenue Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM Revenue

N/A

30 September 2024

CKPT TTM Revenue Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CKPT Revenue Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-46.4%--
3 y3 years-90.4%--
5 y5 years-97.1%--

CKPT Revenue High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-90.4%at low
5 y5 years-97.1%at low
alltimeall time-97.1%at low

Checkpoint Therapeutics Revenue History

DateAnnualQuarterlyTTM
June 2024
-
$41.00 K(+583.3%)
$78.00 K(-24.3%)
Dec 2023
$103.00 K(-46.4%)
$6000.00(-80.6%)
$103.00 K(-39.8%)
Sept 2023
-
$31.00 K(0.0%)
$171.00 K(-9.0%)
June 2023
-
$31.00 K(-11.4%)
$188.00 K(+7.4%)
Mar 2023
-
$35.00 K(-52.7%)
$175.00 K(-8.9%)
Dec 2022
$192.00 K(-28.4%)
$74.00 K(+54.2%)
$192.00 K(+43.3%)
Sept 2022
-
$48.00 K(+166.7%)
$134.00 K(+16.5%)
June 2022
-
$18.00 K(-65.4%)
$115.00 K(-54.4%)
Mar 2022
-
$52.00 K(+225.0%)
$252.00 K(-6.0%)
Dec 2021
$268.00 K(-74.9%)
$16.00 K(-44.8%)
$268.00 K(-3.9%)
Sept 2021
-
$29.00 K(-81.3%)
$279.00 K(+0.4%)
June 2021
-
$155.00 K(+127.9%)
$278.00 K(+68.5%)
Mar 2021
-
$68.00 K(+151.9%)
$165.00 K(-84.6%)
Dec 2020
$1.07 M(-37.4%)
$27.00 K(-3.6%)
$1.07 M(+0.2%)
Sept 2020
-
$28.00 K(-33.3%)
$1.07 M(-19.1%)
June 2020
-
$42.00 K(-95.7%)
$1.32 M(-43.3%)
Mar 2020
-
$972.00 K(+3788.0%)
$2.33 M(+36.3%)
DateAnnualQuarterlyTTM
Dec 2019
$1.71 M(-51.3%)
$25.00 K(-91.1%)
$1.71 M(-63.8%)
Sept 2019
-
$280.00 K(-73.4%)
$4.71 M(+6.2%)
June 2019
-
$1.05 M(+198.6%)
$4.44 M(+26.3%)
Mar 2019
-
$352.00 K(-88.4%)
$3.52 M(+0.3%)
Dec 2018
$3.51 M(+103.2%)
$3.03 M(>+9900.0%)
$3.51 M(+334.4%)
Sept 2018
-
$5000.00(-96.1%)
$807.00 K(-29.9%)
June 2018
-
$127.00 K(-63.0%)
$1.15 M(-16.3%)
Mar 2018
-
$343.00 K(+3.3%)
$1.38 M(-20.3%)
Dec 2017
$1.73 M(-32.9%)
$332.00 K(-4.9%)
$1.73 M(-8.8%)
Sept 2017
-
$349.00 K(-0.6%)
$1.89 M(-9.4%)
June 2017
-
$351.00 K(-49.4%)
$2.09 M(-30.1%)
Mar 2017
-
$693.00 K(+39.2%)
$2.99 M(+16.2%)
Dec 2016
$2.57 M(+335.6%)
$498.00 K(-8.8%)
$2.57 M(+20.3%)
Sept 2016
-
$546.00 K(-56.3%)
$2.14 M(+32.2%)
June 2016
-
$1.25 M(+350.9%)
$1.62 M(+340.3%)
Mar 2016
-
$277.00 K(+326.2%)
$367.00 K(+307.8%)
Dec 2015
$590.00 K
$65.00 K(+160.0%)
$90.00 K(+260.0%)
Sept 2015
-
$25.00 K
$25.00 K

FAQ

  • What is Checkpoint Therapeutics annual revenue?
  • What is the all time high annual revenue for Checkpoint Therapeutics?
  • What is Checkpoint Therapeutics annual revenue year-on-year change?
  • What is the all time high quarterly revenue for Checkpoint Therapeutics?
  • What is the all time high TTM revenue for Checkpoint Therapeutics?

What is Checkpoint Therapeutics annual revenue?

The current annual revenue of CKPT is $103.00 K

What is the all time high annual revenue for Checkpoint Therapeutics?

Checkpoint Therapeutics all-time high annual revenue is $3.51 M

What is Checkpoint Therapeutics annual revenue year-on-year change?

Over the past year, CKPT annual revenue has changed by -$89.00 K (-46.35%)

What is the all time high quarterly revenue for Checkpoint Therapeutics?

Checkpoint Therapeutics all-time high quarterly revenue is $3.03 M

What is the all time high TTM revenue for Checkpoint Therapeutics?

Checkpoint Therapeutics all-time high TTM revenue is $4.71 M